Evidence map›Paper›PMID 37763167›Full record

ArticleJournal of personalized medicine2023

Complement System Proteins in the Human Aqueous Humor and Their Association with Primary Open-Angle Glaucoma.

Ayushi Vashishtha, Sharon W Maina, Jeremy Altman, Garrett Jones, Tae Jin Lee, Kathryn E Bollinger, Lane Ulrich, Marc Töteberg-Harms, Amy J Estes, Wenbo Zhi and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The Role of Complement Dysregulation in Glaucoma.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ayushi VashishthaMorsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Sharon W MainaCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Jeremy AltmanCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Garrett JonesCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Tae Jin LeeCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Kathryn E BollingerDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Lane UlrichDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Marc Töteberg-HarmsDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-2134-1336
Amy J EstesDepartment of Ophthalmology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Wenbo ZhiCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0002-7720-7048
Shruti SharmaCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.
Ashok SharmaCenter for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA.ORCID 0000-0001-9597-4374
Augusta University · USUniversity of South Florida · US

Funding

Module 3: Gene Expression/ProteomicsP30EY031631 · NEI · AUGUSTA UNIVERSITY · PI Xingjun Fan · 2020 to 2026
$3.6M
Proteomic Biomarkers for Glaucomatous Optic NeuropathyR01EY029728 · NEI · AUGUSTA UNIVERSITY · PI SHARMA, ASHOK · 2019 to 2022
$1.5M
NEI NIH HHS P30 EY031631NEI NIH HHS R01 EY029728
6 · The paper itself

Abstract

This study discovers the complement protein profile in the aqueous humor (AH) of human subjects and investigates its association with primary open-angle glaucoma (POAG) pathogenesis. Among the 32 complement proteins identified, 22 were highly abundant and detected in more than 50% of AH samples. The most predominant active complement proteins in the AH are C3, C4B, C4A, CFB, CFD, and C9. Additionally, the most prevalent complement regulators and receptors include CLU, SERPING1, F2, CFH, CFI, and VTN. Significant alterations in complement proteins were observed in individuals with POAG compared to those with cataracts. Specifically, complement protein F2 was upregulated, while C8G, C6, and CFH were downregulated in POAG samples. Stratification of the samples by race and sex revealed distinct alterations of complement proteins in patients with POAG. In the African American cohort, five complement proteins (C4A, C4B, F2, C7, and C3) were upregulated in POAG compared to cataract patients. In the Caucasian cohort, eight complement proteins (C3, SERPING1, CFI, CLU, CFHR1, C8G, C6, and CFH) were downregulated in the POAG samples compared to the cataract samples. Within the male cohort, three complement proteins (CLU, C6, and CFH) were downregulated in POAG patients compared to those with cataracts. Whereas, within the female cohort, two complement proteins (C4B and F2) were upregulated and one (C8G) downregulated in the POAG samples when compared to cataracts. Discerning these changes in the AH complement protein profile will assist in the development of tailored therapies to modulate the complement system for managing ocular disorders. These insights may also lead to novel biomarkers for diagnosing and monitoring disease progression.

Indexed as

aqueous humorcomplement proteinsglaucomamass spectrometryPOAGproteomics

Identifiers

PMID37763167
PMCPMC10532607
OpenAlexW4386894288

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.